Bone resorption, mediated by osteoclasts, is essential for bone growth and repair. Past c-src knockout mice studies have indicated that the protein tyrosine kinase (PTK) activity of c-src is essential for mature osteoclastic activity. The c-src PTK activity is regulated predominately by the phosphorylation status of a C-terminal tyr-527 residue: phosphorylation inactivates, and dephosphorylation activates, c-src PTK activity. The phosphorylation is catalyzed by a cytosolic PTK, Csk, but the identity of the phosphotyrosine phosphatase (PTP) activity that mediates the dephosphorylation is unknown. We have recently cloned a structurally unique PTP, termed PTP-oc, from rabbit osteoclast cDNA library. It is expressed preferentially in osteoclasts and precursors. We have a large body of preliminary data to support that PTP-oc may dephosphorylate c-src and may regulate c-src PTK activity in osteoclasts. These findings led us to formulate a working model, in which PTP-oc acts to dephosphorylate tyr-527 of c-src in osteoclasts, resulting in activation of its PTK activity, which in turn leads to activation of osteoclast activity and resorption. We further speculate that some bone resorption activators may stimulate osteoclastic resorption through an increase in the expression and/or the activity of PTP-oc in osteoclasts; whereas some inhibitors may reduce osteoclastic resorption by reducing the PTP-oc expression and/or activity. This application will test three specific hypotheses: 1) suppression of PTP- oc expression in osteoclasts increases c-src tyr-527 phosphorylation, reduces c-src PTK activity, decreases their resorptive activity, and impairs actions of some resorption activators on their c-src PTK and resorptive activities; 2) overexpression of PTP-oc in osteoclasts reduces tyr-527 phosphorylation of c-src, stimulates c-src PTK activity, increases their resorptive activity, and reduces actions of some resorption inhibibitors on their c-src PTK and resorptive activities; 3) overexpression of an inactive PTP-oc mutant in osteoclasts reduces c-src tyr-527 dephosphorylation, leading to a reduction in c-src PTK activity and a decrease in their osteoclast activity; and it also suppresses the actions of some resorption activators on their c-src PTK and resorptive activities. The first hypothesis will be tested in primary rabbit osteoclasts by using specific PTP-oc antisense oligodeoxynucleotides to suppress PTP-oc expression. The other two hypotheses will be evaluated by stably transfecting either a wild type or a """"""""phosphatase-dead"""""""" PTP-oc inducible vector in a human U937/ osteoclast cell model. The stable clones will be induced to overexpress either the wild-type or mutant PTP-oc for evaluation. If our hypotheses are correct, this work would provide insights into a) molecular mechanism of osteoclastic resorption, b) regulation of osteoclast activity, and c) the role of PTP-oc in bone resorption. PTP-oc may also be used as a screening target to identify new agents that alter bone resorption, and as such this study may identify a potential therapeutic target for development of more specific and safer modulators of bone resorption.

Agency
National Institute of Health (NIH)
Institute
National Institute of Dental & Craniofacial Research (NIDCR)
Type
Research Project (R01)
Project #
5R01DE013097-03
Application #
6379908
Study Section
Orthopedics and Musculoskeletal Study Section (ORTH)
Program Officer
Zhang, Guo He
Project Start
1999-04-01
Project End
2003-03-31
Budget Start
2001-04-01
Budget End
2002-03-31
Support Year
3
Fiscal Year
2001
Total Cost
$269,001
Indirect Cost
Name
Loma Linda University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
City
Loma Linda
State
CA
Country
United States
Zip Code
92350
Lau, K-H William; Wu, Li-Wha; Sheng, Matilda H-C et al. (2006) An osteoclastic protein-tyrosine phosphatase is a potential positive regulator of the c-Src protein-tyrosine kinase activity: a mediator of osteoclast activity. J Cell Biochem 97:940-55
Amoui, Mehran; Suhr, Sung-Min; Baylink, David J et al. (2004) An osteoclastic protein-tyrosine phosphatase may play a role in differentiation and activity of human monocytic U-937 cell-derived, osteoclast-like cells. Am J Physiol Cell Physiol 287:C874-84
Amoui, Mehran; Baylink, David J; Tillman, John B et al. (2003) Expression of a structurally unique osteoclastic protein-tyrosine phosphatase is driven by an alternative intronic, cell type-specific promoter. J Biol Chem 278:44273-80
Kapur, Sonia; Baylink, David J; Lau, K-H William (2003) Fluid flow shear stress stimulates human osteoblast proliferation and differentiation through multiple interacting and competing signal transduction pathways. Bone 32:241-51
Harris, Joseph W; Strong, Donna D; Amoui, Mehran et al. (2002) Construction of a Tc1-like transposon Sleeping Beauty-based gene transfer plasmid vector for generation of stable transgenic mammalian cell clones. Anal Biochem 310:15-26
Koyama, Hiroki; Nakade, Osamu; Takada, Yukihiro et al. (2002) Melatonin at pharmacologic doses increases bone mass by suppressing resorption through down-regulation of the RANKL-mediated osteoclast formation and activation. J Bone Miner Res 17:1219-29
Suhr, S M; Pamula, S; Baylink, D J et al. (2001) Antisense oligodeoxynucleotide evidence that a unique osteoclastic protein-tyrosine phosphatase is essential for osteoclastic resorption. J Bone Miner Res 16:1795-803
Dimai, H P; Domej, W; Leb, G et al. (2001) Bone loss in patients with untreated chronic obstructive pulmonary disease is mediated by an increase in bone resorption associated with hypercapnia. J Bone Miner Res 16:2132-41